Published online 23 December 2002 doi:10.1084/jem.20021429
© Rockefeller University Press,
0022-1007/2003/1/19 $5.00
The Journal of Experimental Medicine, Volume 197, Number 1, 19-26
CD28 Costimulation Is Required for In Vivo Induction of Peripheral Tolerance in CD8 T Cells
Melanie S. Vacchio1 and
Richard J. Hodes1,2
1 Experimental Immunology Branch, National Cancer Institute
2 National Institute on Aging, National Institutes of Health, Bethesda, MD 20892
Address correspondence to M.S. Vacchio, Building 10, Rm. 4B10, 10 Center Dr., Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-1360. Phone: 301-435-6461; Fax: 301-496-0887; E-mail: vacchio{at}nih.gov
Whereas ligation of CD28 is known to provide a critical costimulatory signal for activation of CD4 T cells, the requirement for CD28 as a costimulatory signal during activation of CD8 cells is less well defined. Even less is known about the involvement of CD28 signals during peripheral tolerance induction in CD8 T cells. In this study, comparison of T cell responses from CD28-deficient and CD28 wild-type H-Yspecific T cell receptor transgenic mice reveals that CD8 cells can proliferate, secrete cytokines, and generate cytotoxic T lymphocytes efficiently in the absence of CD28 costimulation in vitro. Surprisingly, using pregnancy as a model to study the H-Yspecific response of maternal T cells in the presence or absence of CD28 costimulation in vivo, it was found that peripheral tolerance does not occur in CD28KO pregnants in contrast to the partial clonal deletion and hyporesponsiveness of remaining T cells observed in CD28WT pregnants. These data demonstrate for the first time that CD28 is critical for tolerance induction of CD8 T cells, contrasting markedly with CD28 independence of in vitro activation, and suggest that the role of CD28/B7 interactions in peripheral tolerance of CD8 T cells may differ significantly from that of CD4 T cells.
Key Words: pregnancy clonal deletion clonal anergy B7 costimulatory molecules cytotoxic T lymphocytes

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Guillonneau, C., Seveno, C., Dugast, A.-S., Li, X.-L., Renaudin, K., Haspot, F., Usal, C., Veziers, J., Anegon, I., Vanhove, B.
(2007). Anti-CD28 Antibodies Modify Regulatory Mechanisms and Reinforce Tolerance in CD40Ig-Treated Heart Allograft Recipients. J. Immunol.
179: 8164-8171
[Abstract]
[Full Text]
-
Chatzidakis, I., Fousteri, G., Tsoukatou, D., Kollias, G., Mamalaki, C.
(2007). An Essential Role for TNF in Modulating Thresholds for Survival, Activation, and Tolerance of CD8+ T Cells. J. Immunol.
178: 6735-6745
[Abstract]
[Full Text]
-
Vacchio, M. S., Olaru, A., Livak, F., Hodes, R. J.
(2007). ATM deficiency impairs thymocyte maturation because of defective resolution of T cell receptor {alpha} locus coding end breaks. Proc. Natl. Acad. Sci. USA
104: 6323-6328
[Abstract]
[Full Text]
-
Vacchio, M. S., Hodes, R. J.
(2005). Fetal Expression of Fas Ligand Is Necessary and Sufficient for Induction of CD8 T Cell Tolerance to the Fetal Antigen H-Y during Pregnancy. J. Immunol.
174: 4657-4661
[Abstract]
[Full Text]
-
Albert, M. H., Yu, X.-Z., Martin, P. J., Anasetti, C.
(2005). Prevention of lethal acute GVHD with an agonistic CD28 antibody and rapamycin. Blood
105: 1355-1361
[Abstract]
[Full Text]
-
Taneja, V., Taneja, N., Behrens, M., Griffiths, M. M., Luthra, H. S., David, C. S.
(2005). Requirement for CD28 May Not Be Absolute for Collagen-Induced Arthritis: Study with HLA-DQ8 Transgenic Mice. J. Immunol.
174: 1118-1125
[Abstract]
[Full Text]
-
Scharschmidt, E., Wegener, E., Heissmeyer, V., Rao, A., Krappmann, D.
(2004). Degradation of Bcl10 Induced by T-Cell Activation Negatively Regulates NF-{kappa}B Signaling. Mol. Cell. Biol.
24: 3860-3873
[Abstract]
[Full Text]